AU2014208383A1 - Neuronal imaging and treatment - Google Patents

Neuronal imaging and treatment Download PDF

Info

Publication number
AU2014208383A1
AU2014208383A1 AU2014208383A AU2014208383A AU2014208383A1 AU 2014208383 A1 AU2014208383 A1 AU 2014208383A1 AU 2014208383 A AU2014208383 A AU 2014208383A AU 2014208383 A AU2014208383 A AU 2014208383A AU 2014208383 A1 AU2014208383 A1 AU 2014208383A1
Authority
AU
Australia
Prior art keywords
radioactive tracer
activity
imaging
data
nervous system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014208383A
Other languages
English (en)
Inventor
Shlomo Ben-Haim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tylerton International Holdings Inc
Original Assignee
Tylerton International Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tylerton International Holdings Inc filed Critical Tylerton International Holdings Inc
Publication of AU2014208383A1 publication Critical patent/AU2014208383A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/037—Emission tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/40—Arrangements for generating radiation specially adapted for radiation diagnosis
    • A61B6/4057—Arrangements for generating radiation specially adapted for radiation diagnosis by using radiation sources located in the interior of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/506—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of nerves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
    • A61B6/5229—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data combining image data of a patient, e.g. combining a functional image with an anatomical image
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T12/00—Tomographic reconstruction from projections
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577—Ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00773—Sensed parameters
    • A61B2018/00839—Bioelectrical parameters, e.g. ECG, EEG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2200/00—Indexing scheme for image data processing or generation, in general
    • G06T2200/04—Indexing scheme for image data processing or generation, in general involving 3D image data
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30048—Heart; Cardiac
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30081—Prostate
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2210/00—Indexing scheme for image generation or computer graphics
    • G06T2210/41—Medical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Optics & Photonics (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Theoretical Computer Science (AREA)
  • Neurosurgery (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
AU2014208383A 2013-01-24 2014-01-24 Neuronal imaging and treatment Abandoned AU2014208383A1 (en)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US201361756112P 2013-01-24 2013-01-24
US61/756,112 2013-01-24
US201361776599P 2013-03-11 2013-03-11
US61/776,599 2013-03-11
US201361803611P 2013-03-20 2013-03-20
US61/803,611 2013-03-20
US201361831664P 2013-06-06 2013-06-06
US61/831,664 2013-06-06
US201361875069P 2013-09-08 2013-09-08
US201361875074P 2013-09-08 2013-09-08
US201361875070P 2013-09-08 2013-09-08
US61/875,074 2013-09-08
US61/875,070 2013-09-08
US61/875,069 2013-09-08
US201461925669P 2014-01-10 2014-01-10
US201461925670P 2014-01-10 2014-01-10
US61/925,669 2014-01-10
US61/925,670 2014-01-10
PCT/IL2014/050090 WO2014115152A1 (en) 2013-01-24 2014-01-24 Neuronal imaging and treatment

Publications (1)

Publication Number Publication Date
AU2014208383A1 true AU2014208383A1 (en) 2015-07-23

Family

ID=51227001

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014208383A Abandoned AU2014208383A1 (en) 2013-01-24 2014-01-24 Neuronal imaging and treatment

Country Status (6)

Country Link
US (1) US20150366523A1 (https=)
EP (1) EP2948188B1 (https=)
JP (1) JP6682273B2 (https=)
CN (1) CN104936623A (https=)
AU (1) AU2014208383A1 (https=)
WO (1) WO2014115152A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2948047B1 (en) * 2013-01-24 2021-03-03 Tylerton International Holdings Inc. Body structure imaging system and method for locating ganglion plexi
US20160220835A1 (en) 2013-09-08 2016-08-04 Tylerton International Inc. Apparatus and methods for diagnosis and treatment of patterns of nervous system activity affecting disease
US10646183B2 (en) 2014-01-10 2020-05-12 Tylerton International Inc. Detection of scar and fibrous cardiac zones
WO2016016837A1 (en) 2014-07-30 2016-02-04 Navix International Limited Probe localization
US11679254B2 (en) * 2016-11-11 2023-06-20 The General Hospital Corporation System and method for using concomitant fields to control peripheral nerve stimulation (PNS) in MRI image encoding
USD878414S1 (en) 2017-04-19 2020-03-17 Navix International Limited Display screen or portion thereof with icon
USD843385S1 (en) 2017-04-19 2019-03-19 Navix International Limited Display screen or portion thereof with graphical user interface
USD918929S1 (en) 2017-09-28 2021-05-11 Navix International Limited Display screen or portion thereof with panoramic view
USD878413S1 (en) 2017-09-28 2020-03-17 Navix International Limited Display screen or portion thereof with icon
USD889476S1 (en) 2017-09-28 2020-07-07 Navix International Limited Display screen or portion thereof with panoramic view
KR102085755B1 (ko) * 2018-04-03 2020-03-06 재단법인대구경북과학기술원 시냅스 영상 촬영 장치 및 그의 구동 방법
US10572697B2 (en) 2018-04-06 2020-02-25 Lam Research Corporation Method of etch model calibration using optical scatterometry
US11921433B2 (en) 2018-04-10 2024-03-05 Lam Research Corporation Optical metrology in machine learning to characterize features
WO2019199697A1 (en) 2018-04-10 2019-10-17 Lam Research Corporation Resist and etch modeling
JP2021522196A (ja) * 2018-04-20 2021-08-30 ザ ジェネラル ホスピタル コーポレイション 血液脳関門を越えて送達するためのアセチル化プロドラッグ
US10977405B2 (en) * 2019-01-29 2021-04-13 Lam Research Corporation Fill process optimization using feature scale modeling
CN113784665B (zh) * 2019-05-03 2024-10-22 皇家飞利浦有限公司 心脏图像的共配准
USD979578S1 (en) * 2021-02-08 2023-02-28 Orthogrid Systems Holdings, Llc Display screen or portion thereof with a graphical user interface
CA3208240A1 (en) * 2021-07-29 2023-02-02 Robert A. Dekemp Improved dosing method for positron emission tomography imaging
US20240350106A1 (en) * 2021-08-17 2024-10-24 University Of Virginia Patent Foundation Systems, methods, and computer readable media for parametric fdg pet quantification, segmentation and classification of abnormalities
GB202213773D0 (en) * 2022-09-21 2022-11-02 Univ Southampton Apparatus and method for monitoring disease
JPWO2024202649A1 (https=) * 2023-03-31 2024-10-03
USD1065246S1 (en) * 2023-04-20 2025-03-04 Histosonics, Inc. Display screen or portion thereof with an animated graphical user interface
USD1075796S1 (en) * 2023-04-20 2025-05-20 Histosonics, Inc. Display screen or portion thereof with an animated graphical user interface
USD1065226S1 (en) * 2023-04-20 2025-03-04 Histosonics, Inc. Display screen or portion thereof with an animated graphical user interface
USD1075797S1 (en) * 2023-04-20 2025-05-20 Histosonics, Inc. Display screen or portion thereof with graphical user interface
CN117078638A (zh) * 2023-08-22 2023-11-17 深圳湾实验室 一种图像处理方法、装置及电子设备

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077035A (en) 1990-05-14 1991-12-31 The University Of Michigan Radioiodinated benzovesamicol analogs for cholinergic nerve mapping
CA2131705C (en) * 1992-03-09 2008-10-21 Aaron G. Filler Image neurography and diffusion anisotropy imaging
US5338852A (en) 1992-06-03 1994-08-16 Regents Of The University Of Minnesota Azavesamicols
IL123220A0 (en) 1995-08-08 1998-09-24 Albany Medical College Ibogamine congeners
US7167748B2 (en) 1996-01-08 2007-01-23 Impulse Dynamics Nv Electrical muscle controller
US6358492B1 (en) 1997-10-07 2002-03-19 Research Triangle Institute Dopamine transporter imaging ligand
US20080228069A1 (en) * 2003-12-01 2008-09-18 Mediphysics, Inc. Novel Differential Imaging Method
US7534418B2 (en) * 2004-12-10 2009-05-19 The Regents Of The University Of Michigan Imaging agents
EP1891899A1 (en) * 2006-08-25 2008-02-27 Multi Magnetics Incorporated Method and system for performing local tomography
TWI618544B (zh) 2006-12-26 2018-03-21 藍瑟斯醫學影像公司 使心臟神經分布顯像之配位體
CN102120039B (zh) * 2011-02-28 2012-10-24 王雪梅 碳-11标记的n-甲基多巴胺在制备正电子药物显像剂中的应用
US9320478B2 (en) * 2011-04-29 2016-04-26 The Board Of Trustees Of The Leland Stanford Junior University Dual-isotope position emitting tomography for disease evaluation
US9101333B2 (en) * 2011-11-14 2015-08-11 Biosense Webster (Israel) Ltd. Integrative atrial fibrillation ablation

Also Published As

Publication number Publication date
JP2016513079A (ja) 2016-05-12
CN104936623A (zh) 2015-09-23
EP2948188B1 (en) 2021-09-08
WO2014115152A1 (en) 2014-07-31
JP6682273B2 (ja) 2020-04-15
US20150366523A1 (en) 2015-12-24
EP2948188A1 (en) 2015-12-02
EP2948188A4 (en) 2016-01-27

Similar Documents

Publication Publication Date Title
EP2948188B1 (en) Neuronal imaging and treatment
US20220133151A1 (en) Body structure imaging
US6026317A (en) Myocardial perfusion imaging during coronary vasodilation with selective adenosine A2 receptor agonists
Marshall et al. Margins to account for cardiac and respiratory motion in cardiac radioablation
Nardone et al. Nuclear medicine and radiotherapy in the clinical management of glioblastoma patients
Jacobson et al. Introduction to cardiac neuronal imaging: a clinical perspective
Graham Non-Invasive Electrocardiographic Mapping of Arrhythmia and Arrhythmogenic substrate in the Human Ventricle
Rowlands Cardiovascular Function in Health and Disease
Camici State of the Art in Cardiac Positron Emission Tomography Wenckebach Lecture
Travin Cardiac Neuronal Imaging with 123 I-mIBG
Schwaiger 2011 SNM Highlights Lecture: Cardiovascular
Schwaiger 2011 SNM Highlights Lecture
Marcu et al. 188 Radiobiological modelling of the interplay between accelerated repopulation and altered fractionation schedules in head and neck cancers
Grosu et al. 187 Hypoxia-pet for radiation treatment planning in head and neck cancer
Hinz et al. BrainPET poster session: in vivo pharmacology and clinical applications

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period